Literature DB >> 8931035

Can biochemical markers predict bone loss at the hip and spine?: a 4-year prospective study of 141 early postmenopausal women.

R W Keen1, T Nguyen, R Sobnack, L A Perry, P W Thompson, T D Spector.   

Abstract

A number of recent studies have suggested that non-invasive measures of bone turnover are associated with bone loss at the forearm in postmenopausal women. Whether bone turnover markers are predictive of bone loss from the clinically important sites of lumbar spine and femoral neck remain unclear, and was the aim of this 4-year prospective study. One hundred and forty-one normal, postmenopausal women (mean age 52.0 +/- 3.3 years, mean menopause duration 20.4 +/- 5.7 months) were recruited for the study in 1988. Fasting early morning samples of blood and urine were collected at the baseline visit and stored at -20 degrees C prior to analysis. Serum was assayed for osteocalcin, oestradiol, oestrone, oestrone sulphate, testosterone, sex hormone binding globulin, dehydroepiandrosterone sulphate and total alkaline phosphatase. Urine was assayed for calcium, hydroxyproline, oestrone glucuronide and the collagen cross-links pyridinoline and deoxypyridinoline using high-performance liquid chromatography. Bone density was measured at the lumbar spine and femoral neck using dual photon absorptiometry at time 0, 12, 24 and 48 months. The mean annual percentage change in bone density (SE) was -1.41% (0.18) at the lumbar spine and -0.86% (0.22) at the femoral neck. There was no evidence of bimodality or a fast loser subgroup as the rates of change were normally distributed. Both simple and multiple stepwise regression analyses revealed no significant correlation between the rates of change in bone density with any biochemical marker, either individually or in combination, despite the study having sufficient power (80%) to detect a correlation of 0.5 between any biochemical marker levels and bone loss. We conclude that single measurements of these markers of bone turnover and endogenous sex hormones appear unlikely to be clinically useful in predicting early postmenopausal bone loss from either the spine or the hip.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931035     DOI: 10.1007/BF01623014

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  30 in total

1.  Urinary oestrogen excretion after the menopause in relation to age and body mass.

Authors:  P A Mole; M H Rae; C R Paterson
Journal:  Ann Nutr Metab       Date:  1989       Impact factor: 3.374

2.  Relationship between bone mass and rates of bone change at appendicular measurement sites.

Authors:  J W Davis; J S Grove; P D Ross; J M Vogel; R D Wasnich
Journal:  J Bone Miner Res       Date:  1992-07       Impact factor: 6.741

3.  Rates of bone loss in normal women: evidence of accelerated trabecular bone loss after the menopause.

Authors:  L Nilas; C Christiansen
Journal:  Eur J Clin Invest       Date:  1988-10       Impact factor: 4.686

4.  Prediction of rapid bone loss in postmenopausal women.

Authors:  C Christiansen; B J Riis; P Rødbro
Journal:  Lancet       Date:  1987-05-16       Impact factor: 79.321

5.  An easy and reliable method for determination of urinary hydroxyproline.

Authors:  J Pødenphant; N E Larsen; C Christiansen
Journal:  Clin Chim Acta       Date:  1984-09-15       Impact factor: 3.786

6.  Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group.

Authors:  S R Cummings; D M Black; M C Nevitt; W Browner; J Cauley; K Ensrud; H K Genant; L Palermo; J Scott; T M Vogt
Journal:  Lancet       Date:  1993-01-09       Impact factor: 79.321

7.  Sex steroids and bone mass. A study of changes about the time of menopause.

Authors:  C Slemenda; S L Hui; C Longcope; C C Johnston
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

8.  Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.

Authors:  P Garnero; W J Shih; E Gineyts; D B Karpf; P D Delmas
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

9.  Effect of calcium supplementation on bone loss in postmenopausal women.

Authors:  I R Reid; R W Ames; M C Evans; G D Gamble; S J Sharpe
Journal:  N Engl J Med       Date:  1993-02-18       Impact factor: 91.245

10.  A relationship between sex hormone binding globulin and dehydroepiandrosterone sulfate in normally menstruating females.

Authors:  N C Wathen; L A Perry; E Rubenstein; T Chard
Journal:  Gynecol Endocrinol       Date:  1987-03       Impact factor: 2.260

View more
  12 in total

1.  Lycopene consumption decreases oxidative stress and bone resorption markers in postmenopausal women.

Authors:  L G Rao; E S Mackinnon; R G Josse; T M Murray; A Strauss; A V Rao
Journal:  Osteoporos Int       Date:  2006-08-29       Impact factor: 4.507

Review 2.  An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice.

Authors:  D J Leeming; P Alexandersen; M A Karsdal; P Qvist; S Schaller; L B Tankó
Journal:  Eur J Clin Pharmacol       Date:  2006-08-16       Impact factor: 2.953

3.  Prediction of bone loss using biochemical markers of bone turnover.

Authors:  J Lenora; K K Ivaska; K J Obrant; P Gerdhem
Journal:  Osteoporos Int       Date:  2007-04-18       Impact factor: 4.507

Review 4.  Fast and slow bone losers. Relevance to the management of osteoporosis.

Authors:  S Hough
Journal:  Drugs Aging       Date:  1998       Impact factor: 3.923

Review 5.  2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

Authors:  Jacques P Brown; Robert G Josse
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

6.  Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosis.

Authors:  Markus J Seibel
Journal:  Clin Biochem Rev       Date:  2006-08

7.  Genetic and environmental determinants on bone loss in postmenopausal Caucasian women: a 14-year longitudinal twin study.

Authors:  G Zhai; T Andrew; B S Kato; G M Blake; T D Spector
Journal:  Osteoporos Int       Date:  2008-09-23       Impact factor: 4.507

8.  Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis.

Authors:  P Szulc; P D Delmas
Journal:  Osteoporos Int       Date:  2008-07-16       Impact factor: 4.507

9.  Urinary excretion of the pyridinium cross-links of collagen in systemic lupus erythematosus.

Authors:  Y Kipen; R Will; B J Strauss; E F Morand
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 10.  Markers of bone remodelling in metabolic bone disease.

Authors:  M C de Vernejoul
Journal:  Drugs Aging       Date:  1998       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.